Northern Trust
ACLX

Northern Trust’s Arcellx ACLX Stock Holding History

Northern Trust’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.2M Buy
350,065
+28,272
+9% +$2.5M 0.01% 1242
2025
Q4 		$21M Sell
321,793
-12,758
-4% -$1.02M ﹤0.01% 1618
2025
Q3 		$27.5M Sell
334,551
-11,424
-3% -$822K ﹤0.01% 1495
2025
Q2 		$22.8M Sell
345,975
-57,866
-14% -$3.6M ﹤0.01% 1566
2025
Q1 		$26.5M Sell
403,841
-6,892
-2% -$467K ﹤0.01% 1464
2024
Q4 		$31.5M Buy
410,733
+26,625
+7% +$2.3M ﹤0.01% 1419
2024
Q3 		$32.1M Buy
384,108
+33,528
+10% +$2.23M 0.01% 1321
2024
Q2 		$19.3M Sell
350,580
-8,880
-2% -$483K ﹤0.01% 1577
2024
Q1 		$25M Sell
359,460
-3,961
-1% -$251K ﹤0.01% 1438
2023
Q4 		$20.2M Sell
363,421
-4,030
-1% -$182K ﹤0.01% 1612
2023
Q3 		$13.2M Buy
367,451
+7,901
+2% +$272K ﹤0.01% 1815
2023
Q2 		$11.4M Buy
359,550
+93,386
+35% +$3.57M ﹤0.01% 1967
2023
Q1 		$8.2M Sell
266,164
-10,814
-4% -$328K ﹤0.01% 2151
2022
Q4 		$8.58M Buy
276,978
+21,622
+8% +$496K ﹤0.01% 2113
2022
Q3 		$4.79M Buy
255,356
+158,632
+164% +$3.04M ﹤0.01% 2511
2022
Q2 		$1.75M Buy
96,724
+10,620
+12% +$137K ﹤0.01% 3127
2022
Q1 		$1.21M Buy
+86,104
New +$1.44M ﹤0.01% 3345

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Northern Trust's ACLX Position: Q1 2026 in Review

Northern Trust increased its Arcellx (ACLX) stake by 8.8% in Q1 2026, buying an estimated $2.5M and bringing the position to 350,065 shares worth $40.2M. The position accounts for 0.01% of the portfolio, ranked #1242.

Northern Trust first reported a position in ACLX in Q1 2022 and has held it in 17 quarters since. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Northern Trust held 350,065 shares of Arcellx worth $40.2M as of Q1 2026.
  • Northern Trust bought 28,272 Arcellx shares in Q1 2026, an estimated $2.5M.
  • Arcellx made up 0.01% of Northern Trust's portfolio in Q1 2026, its #1242 holding.
  • Northern Trust first reported a position in Arcellx in Q1 2022 and has held it in 17 quarters since.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.